Clinical Trial Agreement Template for the United Arab Emirates

A Clinical Trial Agreement is a comprehensive legal contract that establishes the framework for conducting pharmaceutical research in the United Arab Emirates. This document creates binding obligations between sponsors, research institutions, principal investigators, and other parties involved in clinical trials. Under UAE law, this agreement is mandatory for any clinical research involving human subjects and must comply with strict federal healthcare regulations to ensure patient safety and data integrity.

When do you need this document?

You need a Clinical Trial Agreement whenever conducting clinical research in the UAE involving pharmaceutical products, medical devices, or therapeutic procedures. This includes Phase I through IV clinical trials sponsored by pharmaceutical companies, investigator-initiated studies at UAE hospitals and research centers, and multi-center trials involving UAE sites. The agreement is essential when establishing partnerships between international pharmaceutical sponsors and local research institutions, engaging Contract Research Organizations (CROs) for trial management, or coordinating with UAE regulatory authorities including MOHAP, DHA, or HAAD. Academic medical centers conducting research with industry funding also require this agreement to define their collaborative relationships and compliance obligations.

Key legal considerations

Your Clinical Trial Agreement must address several critical legal provisions to ensure regulatory compliance and risk management. Patient safety protocols must align with Good Clinical Practice standards and include provisions for adverse event reporting, data monitoring, and emergency procedures. Intellectual property clauses should clearly define ownership of research data, inventions, and publication rights between sponsors and investigators. Financial arrangements require transparent disclosure of payments, budgets, and cost allocations to comply with UAE anti-corruption laws. Data protection provisions must address patient confidentiality, cross-border data transfers, and compliance with UAE Federal Law No. 2 of 2019 on health information technology. Insurance and liability coverage must be adequate to protect all parties, with clear indemnification clauses addressing medical liability under Federal Law No. 4 of 2016.

Legal requirements in United Arab Emirates

Clinical Trial Agreements in the UAE must comply with Federal Law No. 4 of 2016 (Medical Liability Law), which governs medical liability and patient rights in clinical research. Cabinet Decision No. 31 of 2021 establishes mandatory Good Clinical Practice standards that must be incorporated into your agreement terms. Federal Law No. 8 of 2019 regulates pharmaceutical products and clinical trial authorization processes, requiring compliance with MOHAP approval procedures. Your agreement must include provisions for Ethics Committee approval and ongoing oversight as mandated by UAE regulatory guidelines. The contract should address health data protection requirements under Federal Law No. 2 of 2019, particularly for electronic health records and cross-border data sharing. Local health authority requirements from DHA or HAAD must be incorporated where applicable, and the agreement should specify procedures for regulatory inspections and compliance monitoring throughout the trial duration.